Literature DB >> 11215789

Recommended childhood immunization schedule--United States, 2001.

.   

Abstract

Each year, CDC's Advisory Committee on Immunization Practices (ACIP) reviews the recommended childhood immunization schedule to ensure that it remains current with changes in manufacturers' vaccine formulations, revisions in recommendations for the use of licensed vaccines, and recommendations for newly licensed vaccines. This report presents the recommended childhood immunization schedule for 2001 (Figure 1) and documents the changes that have occurred since the January 2000 publication.

Mesh:

Substances:

Year:  2001        PMID: 11215789

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  8 in total

1.  Extra-immunization as a clinical indicator for fragmentation of care.

Authors:  Paul M Darden; Kristina K Gustafson; Paul J Nietert; Robert M Jacobson
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

2.  Childhood vaccination providers in the United States.

Authors:  Charles W LeBaron; Bridget Lyons; Mehran Massoudi; John Stevenson
Journal:  Am J Public Health       Date:  2002-02       Impact factor: 9.308

3.  Childhood vaccine purchase costs in the public sector: past trends, future expectations.

Authors:  Matthew M Davis; Jessica L Zimmerman; John R C Wheeler; Gary L Freed
Journal:  Am J Public Health       Date:  2002-12       Impact factor: 9.308

Review 4.  Active immunization in the United States: developments over the past decade.

Authors:  P H Dennehy
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

5.  Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for auantitation of antibodies to tetanus, diphtheria, and Haemophilus influenzae Type b.

Authors:  Jerry W Pickering; Thomas B Martins; M Carl Schroder; Harry R Hill
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

Review 6.  DTPa-HBV-IPV/Hib vaccine (Infanrix hexa).

Authors:  Monique P Curran; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Rapid decline of anti-pneumococcal antibody levels in nephrotic children.

Authors:  Ayfer Gür Güven; Sema Akman; Elif Bahat; Mustafa Senyurt; Selma Yüzbey; Aysen Uguz; Olcay Yegin
Journal:  Pediatr Nephrol       Date:  2003-11-25       Impact factor: 3.714

Review 8.  Hepatitis A, hepatitis B, and combination hepatitis vaccines for immunoprophylaxis: an update.

Authors:  Raymond S Koff
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.487

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.